FDA NDC Directory · JSON-LD · Markdown

VPRIV

NDC 54092-701 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namevelaglucerase alfa
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryBiologic License Application · App BLA022575
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsVELAGLUCERASE ALFA (2.5 mg/mL)
Marketing started20100226
Package count1

External sources

Source: openFDA. Public-domain (CC0).